Infectious disease pharmacotherapy in internal medicine inpatients
Non-cognitive educational influences and experiences of pharmacy students
Education & Experience
Education
PGY2 Residency in Internal Medicine, Infectious Diseases, and Academics, Duke University Medical Center & Campbell University School of Pharmacy, Durham NC, 2004-2005
PGY1 Pharmacy Practice Residency (ASHP-accredited), Parkland Health & Hospital System, Dallas, TX, 2003-2004
Doctor of Pharmacy, University of Oklahoma College of Pharmacy, Oklahoma City, OK, 1999-2003
Pre-pharmacy studies, University of Oklahoma, Norman, OK, 1997-1999
Teaching Experience
PHAR 7004: Adult Medicine I Practicum, OUMC Presbyterian Tower, Oklahoma City
PHAR 7812: Advanced Drug Literature Evaluation
PHAR 7873: Pharmaceutical Care VII (Infectious Diseases Module)
PHAR 7970: Seminar in Advanced Pharmacy Practice
PA 7106: Pharmacotherapeutics
PERI 5012 - PHSC 5012: Advanced Clinical Pharmacotherapeutics
Honors & Service
Memberships
2005-Present: Oklahoma Society of Health System Pharmacists (OSHP)
2005-Present: American Association of Colleges of Pharmacy (AACP)
2005-Present: Oklahoma City Medical Dental & Pharmacy Society (OKC MeDePhar)
2005-Present: Society of Infectious Diseases Pharmacists (SIDP)
2004-Present: American College of Clinical Pharmacy (ACCP)
2003-Present: American Society of Health-System Pharmacists (ASHP)
Service
2005-Present: Clinical Pharmacist, Internal Medicine, OUMC Presbyterian Tower, Oklahoma City
2007-Present: Residency Program Director, PGY1 Pharmacy Practice Residency
2007-Present: OU COP Residency Review Committee
2005-Present: OU COP Admissions Committee
Selected Publications & Presentations
Smith WJ, Drew RH. Telavancin: A new lipoglycopeptide for gram-positive infections. Drugs of Today 2009; 45(3): 159-173.
Smith WJ, Drew RH, Perfect JR. Posaconazole's impact on prophylaxis and treatment of invasive fungal infections: An update. Expert Review of Anti-infective Therapy 2009; 7(2): 165-181.
Gibbs WJ, Cooper TW, Bronze MS, Greenfield RA. Symposium on antimicrobial therapy: V. Other ß –lactam antimicrobials.J Okla State Med Assoc 2007;100:23-5.
Cooper TW, Gibbs WJ, Bronze MS, Greenfield RA. Symposium on antimicrobial therapy: IV. The cephalosporins. J Okla State Med Assoc 2006;99:579-84.
Cooper TW, Gibbs WJ, Bronze MS, Greenfield RA. Symposium on antimicrobial therapy: II. Introduction to the ß-lactam antibiotics. J Okla State Med Assn 2006;99:516-20.
12/15/2006 - 08/1/2008 American Foundation for Pharmaceutical Education (AFPE) - Discovering the learning experiences of high-achieving pharmacy students: using the grounded theory approach